VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,596,000 | -42.9% | 76,800 | -60.6% | 0.02% | -25.9% |
| Q3 2017 | $2,793,000 | -17.2% | 194,900 | 0.0% | 0.03% | -22.9% |
| Q2 2017 | $3,372,000 | +56.8% | 194,900 | 0.0% | 0.04% | +45.8% |
| Q1 2017 | $2,150,000 | -24.0% | 194,900 | 0.0% | 0.02% | -33.3% |
| Q4 2016 | $2,830,000 | -40.9% | 194,900 | 0.0% | 0.04% | -33.3% |
| Q3 2016 | $4,785,000 | +21.9% | 194,900 | 0.0% | 0.05% | +31.7% |
| Q2 2016 | $3,925,000 | -23.4% | 194,900 | 0.0% | 0.04% | -24.1% |
| Q1 2016 | $5,126,000 | -87.1% | 194,900 | -50.0% | 0.05% | -85.0% |
| Q4 2015 | $39,644,000 | +34.7% | 390,000 | +136.4% | 0.36% | +20.9% |
| Q3 2015 | $29,433,000 | -19.7% | 165,000 | 0.0% | 0.30% | +10.4% |
| Q2 2015 | $36,655,000 | +13.9% | 165,000 | +1.9% | 0.27% | -2.2% |
| Q1 2015 | $32,176,000 | +38.8% | 162,000 | 0.0% | 0.28% | +23.9% |
| Q4 2014 | $23,184,000 | +28.0% | 162,000 | +17.4% | 0.22% | +17.5% |
| Q3 2014 | $18,106,000 | +4.0% | 138,000 | 0.0% | 0.19% | -7.4% |
| Q2 2014 | $17,405,000 | -0.7% | 138,000 | +3.8% | 0.20% | -5.6% |
| Q1 2014 | $17,533,000 | -4.9% | 133,000 | -15.3% | 0.22% | -20.3% |
| Q4 2013 | $18,432,000 | +28.0% | 157,000 | +13.8% | 0.27% | +5.4% |
| Q3 2013 | $14,398,000 | +21.2% | 138,000 | 0.0% | 0.26% | +2.0% |
| Q2 2013 | $11,879,000 | – | 138,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |